A specialized perspective to expand your patients’ options.
If you are a physician and want to assess whether regenerative medicine could be an option for one of your patients, you can consult their case with LYRACELL.
Interdisciplinary teamLYRACELL Lab · Moviglia MethodCoordinated follow-upBuenos Aires

Your knowledge of the patient, our experience in cell therapy.
We propose a joint effort between you, as the referring physician, and our medical team. We contribute our experience in cell therapy and regenerative medicine; you contribute your knowledge of the patient: their history, their progress and their context. This collaboration makes it possible to make better-informed decisions, always with the patient in mind.
Together we review the available clinical information, assess whether the treatment may be indicated and share every decision. During and after treatment, we maintain open communication with you to coordinate your patient’s follow-up where they live.

A clear process to share information and evaluate the case.
You can consult a case even if you don’t yet know whether cell therapy may be indicated.
LYRACELL evaluates patients with conditions within its areas of care, including orthopedics, neurology, cardiac health, respiratory health, intimate health and oral health.
The possible indication for cell therapy depends on each patient’s diagnosis, degree of involvement, history, available studies and clinical goals.

Access to the scientific foundations of the Moviglia Method.
You can review the explanation of the method, the work of LYRACELL Lab and the scientific publications linked to its development. Our team can also provide clinical and scientific information to help you evaluate a possible referral.
Everything you need to know about referring a patient
No. First, the LYRACELL medical team evaluates the case. Only if the patient is a candidate for cell therapy do we send you a treatment proposal with its rationale, goals and limits. A joint consultation is then held between you, your patient and a physician from our team, and the decision to move forward is the patient’s.
No. You remain your patient’s treating physician. Our team complements your approach with its experience in cell therapy and regenerative medicine. With the patient’s authorization, we stay in communication with you to support the continuity of their care.
The diagnosis, a summary of the medical history (relevant history and progress) and the available studies, always with the patient’s authorization. If necessary, our team may request additional studies.
Yes, always with the patient’s authorization. We agree with you on the form and frequency of communication according to the needs of each case. Follow-up is carried out together with you.
Yes. You can talk with the LYRACELL medical team before making a formal referral to guide the next steps.
Let’s talk about your patient.
Share the case with our medical team to assess whether cell therapy may be indicated.




